IRVINE, Calif., June 13, 2023 /PRNewswire/ — Smart Health Diagnostics Company (“SHDx” or “the Company”), a developer of precision diagnostic tests that address unmet clinical needs in pathology and vascular inflammation for advancing today’s standards of care, announced that CEO and Chairman Mitch Levine is featured in the June 8, 2023 edition of Med Tech […]
SmartHealth name unifies multi-function operating platform with smart science diagnostics product suite under common brand
Highly regarded diagnostics industry executive and capital markets expert to guide planned growth and value creation for evolutionary data-to-diagnostics platform company
Company announces its business strategy including test development, commercialization, intellectual property, and reimbursement initiatives
Susie Lu as President of Laboratory Services for all Predictive Health Diagnostics Company businesses.
Larry Dentice as Chief Commercial Officer. Mr. Dentice has also stepped into a board role following the departure of longtime board member Munira Mubarak.
Morningstar to bring much needed laboratory service resources, including COVID-19 antibody testing, to urban and rural communities statewide
PULS Test vascular inflammation biomarkers and scores reveal risk of developing acute coronary syndrome (ACS) which can be increased in mRNA COVID-19 vaccinated patients
AI-derived imaging platform expands Company’s test development expertise to create next generation diagnostics for pathology
LIS system enables scalable functionality and big data analysis capabilities
Expanding in-network status reflects strong demand and utilization of the PULS Cardiac Test™ and DIABETESpredict™ in healthcare settings nationwide
Distribution targeted to high at-risk co-morbid patient populations
